|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 559.20 CHF | -0.89% |
|
+1.01% | +3.98% |
| 14/01 | Lonza Group AG Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 10:30 AM | |
| 18/12 | Swiss trade surplus at CHF 3.841 bln in November | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LONZA GROUP AG | Other Biotechnology & Medical Research | -0.89% | +1.01% | +3.98% | +0.87% | -4.80% | 4.89TCr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LONN Stock
- Charts Lonza Group AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition